Persistent parvovirus B19 infections in immunocompromised children

被引:38
|
作者
Flunker, G
Peters, A
Wiersbitzky, S
Modrow, S
Seidel, W
机构
[1] Ernst Moritz Arndt Univ Greifswald, Abt Virol, Inst Med Mikrobiol, D-17487 Greifswald, Germany
[2] Ernst Moritz Arndt Univ Greifswald, Klin & Poliklin Kindermed, Zentrum Kinder & Jugendmed, D-17487 Greifswald, Germany
[3] Univ Regensburg, Inst Med Mikrobiol & Hyg, D-93053 Regensburg, Germany
关键词
parvovirus B19 persistence; patients with immune defect; PCR; nonstructural protein; immune response;
D O I
10.1007/s004300050063
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunocompromised patients have been shown to suffer from prolonged viral infections often without detectable immune response. Here chronic infections with low virus levels can be frequently observed. In these patients viral DNA can be detected over long periods by polymerase chain reaction (PCR). In this study parvovirus B19 presence was assessed by PCR, immunoblot and enzyme-linked immunosorbent assay in sera from children with mainly oncological and hematological diseases. In 45% of sera B19 DNA was observed. Of the children 25% had IgG antibodies to viral protein 1 and 2 (VP1/2) and 15% to nonstructural protein 1 (NS 1). In 6% of children IgM antibodies to VP1/2 were detected. These results indicate that the number of children with immune response to B19 proteins is distinctly lower than the number of children with B19 DNA. Transfusions of blood products might have been a possible route for B19 infection. Establishment and maintenance of a persistent parvovirus B19 infection with or without immune response are enhanced in the analyzed immunocompromised children in comparison with immunocompetent children. A persistence of B19 DNA was demonstrated up to 10 months in patients sera.
引用
收藏
页码:189 / 194
页数:6
相关论文
共 50 条
  • [31] MANIFESTATIONS AND TREATMENT OF HUMAN PARVOVIRUS B19 INFECTION IN IMMUNOCOMPROMISED PATIENTS
    KOCH, WC
    MASSEY, G
    RUSSELL, CE
    ADLER, SP
    JOURNAL OF PEDIATRICS, 1990, 116 (03): : 355 - 359
  • [32] B19 PARVOVIRUS
    YOUNG, NS
    BAILLIERES CLINICAL HAEMATOLOGY, 1995, 8 (01): : 25 - 56
  • [33] Parvovirus B19
    Bültmann, BD
    Sotlar, K
    Klingel, K
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19): : 2006 - 2007
  • [34] Parvovirus B19
    Bundesgesundheitsblatt, 1998, 41 (2): : 83 - 87
  • [35] Parvovirus B19
    Burger, R
    Gerlich, W
    Gürtler, L
    Heiden, M
    Kretschmer, V
    Lefèvre, H
    Löwer, J
    Montag-Lessing, T
    Neumann, R
    Pauli, G
    Seitz, R
    Schlenkrich, U
    Werner, E
    Illkommen, HW
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2005, 32 (3-4) : 121 - 126
  • [36] Parvovirus B19
    Landry, Marie Louise
    MICROBIOLOGY SPECTRUM, 2016, 4 (03):
  • [37] Parvovirus B19
    Burger, R
    Gerlich, W
    Gürtler, L
    Heiden, M
    Kretschner, V
    Lefèvre, H
    Löwer, J
    Montag-Lessing, T
    Neumann, R
    Pauli, G
    Seitz, R
    Schlenkrich, U
    Werner, E
    Willkomen, H
    INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN, 1998, 25 : 97 - 102
  • [38] Chronic hepatitis caused by persistent parvovirus B19 infection
    Trine H Mogensen
    Jens Magnus B Jensen
    Stephen Hamilton-Dutoit
    Carsten S Larsen
    BMC Infectious Diseases, 10
  • [39] Chronic hepatitis caused by persistent parvovirus B19 infection
    Mogensen, Trine H.
    Jensen, Jens Magnus B.
    Hamilton-Dutoit, Stephen
    Larsen, Carsten S.
    BMC INFECTIOUS DISEASES, 2010, 10
  • [40] Congenital Human Parvovirus B19 Infection With Persistent Viremia
    Hudson, Anthony C.
    Montegudo, Anna E.
    Steele, Russell W.
    CLINICAL PEDIATRICS, 2015, 54 (05) : 409 - 413